Assignment: Buy-side consulting services for equity acquisition in a $20 million bio-pharmaceuticals firm.

Assignment Timeframe: March-April 1997

Background: International pharmaceutical firm (client) looking to acquire strategic equity ownership in critical drug component supplier (target company).

Objective/Scope of services: Buy-side assistance to client - pre-acquisition due diligence on target company, advisory services and negotiation support.

My role:
- Prepared pre-acquisition information memorandum on target company
- Provided valuation guidance to client
- Advised on regulations governing foreign acquisition of public stock
- Led price-value analysis during negotiations

Results:



- Purchase of 28% equity interest successfully negotiated – partially through purchase of existing owner stock, and partially through issue of new stock
- Transaction closed at 40% premium over prevailing stock market price
- Strategic value of transaction reflected in stock price increase that exceeded deal price.


Email:mohitm AT alumni.carnegiemellon.edu